Source: International Congress 2017 – Clinical problems in lung diseases
Disease area: Respiratory infections, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Skoczynski (Katowice, Poland). Assessment of the probability of lung cancer diagnosis using authorial predictive scale. Pilot study.. 733

Member's Comments

No comment yet.

Related content which might interest you: Prognostic value of symptoms at lung cancer diagnosis: a two-year observational study Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Performance scores in patients with suspected lung cancer: reliability of scoring and impact on treatment Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Observations on quality of life assessments using functional assessment of cancer-Lung (FACT-L) in patients under lung cancer chemotherapy. Ongoing study Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Australia-modified Karnofsky performance scale in patients with COPD and lung cancer patients: A pooled data analysis Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 Decisional algorithm in the differential diagnosis of lung outcomes from COVID-19. Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021 The assessment of the effect of changes in lung cancer follow-up period to the quality of life by using EQ-5D questionnaire and follow data (the project of AKAYAK-1) Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Prognostic usefulness of severity scales for the initial assessment of elderly people with a diagnosis of pneumonia due to COVID-19. Design of a multivariate predictive model of mortality. Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 A study of design an original questionnaire for evaluating risks of lung cancer Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 Development and validation of a prognostic index for survival in patients with non-small-cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Diagnostic delay time of lung cancer in a community study Source: Annual Congress 2008 - Various aspects of thoracic oncology Year: 2008 Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2012; 39: 9-28 Year: 2012 Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2011; 39: 9-28 Year: 2012 Impact of frailty on interpretability of spirometry: The Rotterdam study Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting? Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Probability of malignancy based on automatic segmentation and software measurements of nodules in the Danish lung cancer screening trial (DLCST) Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Visual analogue scores for interstitial lung disease: a prospective validation study Source: International Congress 2017 – Lung function testing in different patient categories Year: 2017 Lung cancer risk prediction model based on data of the SOS trial (single center non-randomized lung cancer early detection trial) Source: International Congress 2014 – Risk assessment and tracheal reconstructions Year: 2014 FACT-L (functional assessment of cancer therapy-lung) psychometric properties of the Turkish version of quality of life scale (validity and reliability) and determination using the clinic (Akkaya-1 project) Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013